News | April 14, 2026
NASA’s Artemis II mission to on board Opella’s Dulcolax for lunar orbit mission
A brand from Opella will be part of the official NASA astronaut formulary
A brand from Opella will be part of the official NASA astronaut formulary
Lupin's R&D teams are working on products with a near-zero global warming potential propellant
Agreement further expands Aptar Pharma’s leading respiratory portfolio
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
New inhalers would have near-zero Global Warming Potential propellant
Subscribe To Our Newsletter & Stay Updated
